Cyclacel Pharmaceuticals Reports First Quarter 2018 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. PTC
2. NVDA
3. PCVX
4. META
5. MSFT
6. SPY
7. GOOGL
8. GMAB
9. USO
10. AMD

Go back to Cyclacel Pharmaceuticals Reports First Quarter 2018 Financial Results

Cyclacel Pharma (CYCC) Reports Q1 Loss of $0.38

May 14, 2018 4:16 PM EDT

Cyclacel Pharma (NASDAQ: CYCC) reported Q1 EPS of ($0.38), versus ($0.12) reported last year.

As of March 31, 2018, cash and cash equivalents totaled $21.7 million, compared to $23.9 million as of December 31, 2017. The decrease of $2.2 million was primarily due to net cash used in operating activities.

For... More